RecruitingNCT05964504

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Improving Survival for Those With Metastatic Lobular Breast Cancer Through Development of the Multi-center PLUMB Registry-a Prospective Study of LobUlar Metastatic Breast Cancer


Sponsor

University of California, San Francisco

Enrollment

12 participants

Start Date

Dec 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
  • Age \>=18 years
  • Any receptor subtype.
  • Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria3

  • Stage I-III breast cancer.
  • Lack of lobular histology on tumor biopsy.
  • Other active cancer (prior treated cancer with no current evidence of disease is allowed).

Interventions

PROCEDUREBlood Specimen

Blood will be drawn via venipuncture


Locations(4)

University of California, San Diego

San Diego, California, United States

University of California, San Francisco

San Francisco, California, United States

Abramson Cancer Center

Philadelphia, Pennsylvania, United States

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05964504


Related Trials